These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6091724)

  • 1. Controlled trials of fish oil supplements on plasma lipid concentrations.
    Sanders TA; Mistry M
    Br J Clin Pract Suppl; 1984; 31():78-84. PubMed ID: 6091724
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of fish oils on plasma lipid levels in hyperlipidemics].
    Skorepa J; Hrabák P; Zák A; Zeman M; Sindelková E
    Cas Lek Cesk; 1985 Aug; 124(31):970-3. PubMed ID: 3896497
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
    Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP
    Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consumption of fish fats: effect on plasma lipids].
    Oliván B; Tejerina E; Rodríguez-Coira A; Rubio MA; Cabrerizo L; Romeo S
    Rev Clin Esp; 1988 Dec; 183(9):452-4. PubMed ID: 3238097
    [No Abstract]   [Full Text] [Related]  

  • 5. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia.
    Sanders TA; Sullivan DR; Reeve J; Thompson GR
    Arteriosclerosis; 1985; 5(5):459-65. PubMed ID: 4038159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum lipid concentration in familial hyperlipoproteinemia type IV. Treatment with vitamin C and unsaturated fatty acids].
    Kábrt J; Sobra J; Procházková R
    Cas Lek Cesk; 1983 May; 122(21):658-62. PubMed ID: 6871949
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fish, liver oil and hyperlipemia].
    Ongkiehong M; Nordøy A
    Tidsskr Nor Laegeforen; 1986 Apr; 106(11):912-3. PubMed ID: 3726814
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of lipanthyl on parameters of lipid metabolism in patients with primary hyperlipoproteinemia].
    Sznajd J; Magdoń M; Idzior B; Konarska R; Malczewska M; Czarnecka H
    Przegl Lek; 1984; 41(2):217-21. PubMed ID: 6377392
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis and MaxEPA.
    Cendrowski W
    Br J Clin Pract; 1986 Sep; 40(9):365-7. PubMed ID: 3542002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled clinical trial of a new drug (plafibride) for the treatment of hyperlipoproteinemia type IV (author's transl)].
    Ferreira Montero IJ; Gutiérrez Martín M; del Río Ligorit A; Casasnovas Lenguas JA; Cornudella Lacasa R
    Med Clin (Barc); 1982 May; 78(9):380-5. PubMed ID: 7047926
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
    Naruszewicz M; Nowicka G; Szostak WB; Kłosiewicz-Latoszek L
    Kardiol Pol; 1982; 25(7-8):527-31. PubMed ID: 7169740
    [No Abstract]   [Full Text] [Related]  

  • 12. [1,5-dicoffeechinic acid in the treatment of hypertriglyceridemia].
    Wojcicki J; Olejak B; Pieczul-Mróz J; Torbus-Lisiecka B; Bukowska H; Gregorczyk J
    Przegl Lek; 1982; 39(9):601-6. PubMed ID: 6897455
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia.
    Agostoni C; Scaglioni S; Bonvissuto M; Bruzzese MG; Giovannini M; Riva E
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):111-5. PubMed ID: 11237478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
    Sznajderman M
    Przegl Lek; 1984; 41(7):493-9. PubMed ID: 6390536
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fish oil supplementation affects serum fatty acid concentrations in horses.
    O'Connor CI; Lawrence LM; Hayes SH
    J Anim Sci; 2007 Sep; 85(9):2183-9. PubMed ID: 17504965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plafibride treatment of hyperlipidemias type II and IV].
    Soler J; Vinzia C; Gómez JM; Morató J
    Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
    [No Abstract]   [Full Text] [Related]  

  • 18. [Eicosapentaenoic acid ethyl esters].
    Ohtsuka S
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():489-93. PubMed ID: 17824076
    [No Abstract]   [Full Text] [Related]  

  • 19. MaxEPA in multiple sclerosis.
    French JM
    Br J Clin Pract Suppl; 1984; 31():117-21. PubMed ID: 6091716
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of omega-3 and omega-6 fatty acid-rich oils on the cardiovascular system of thermally injured rabbits: changes in plasma triglycerides, plasma cholesterol, relative blood viscosity, platelet count, and bleeding time.
    Kirmani ZA; Baxter CR; Gorman MA; Ashby J; Ireton-Jones C; Liepa GU
    J Burn Care Rehabil; 1995; 16(3 Pt 1):306-15. PubMed ID: 7673312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.